万邦医药：10月22日召开董事会会议

Group 1 - Wanbang Medical (SZ 301520) announced on October 22 that its third board meeting for 2025 was held, where the "2025 Q3 Report" and other documents were reviewed [1] - For the year 2024, Wanbang Medical's revenue composition is entirely from the CRO industry, accounting for 100.0% [1] - As of the report, Wanbang Medical has a market capitalization of 2.8 billion yuan [1]